WEKO3
アイテム
{"_buckets": {"deposit": "b51ecb7c-fe68-4ca3-adcd-f0e8089cf4d5"}, "_deposit": {"created_by": 3, "id": "17023", "owners": [3], "pid": {"revision_id": 0, "type": "depid", "value": "17023"}, "status": "published"}, "_oai": {"id": "oai:sucra.repo.nii.ac.jp:00017023", "sets": ["396"]}, "author_link": ["27704"], "item_120_alternative_title_1": {"attribute_name": "タイトル(別言語)", "attribute_value_mlt": [{"subitem_alternative_title": "Value-Added Productivity in Big Japanese Pharmaceutical Companies"}]}, "item_120_biblio_info_8": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2014", "bibliographicIssueDateType": "Issued"}, "bibliographicPageEnd": "209", "bibliographicPageStart": "179", "bibliographicVolumeNumber": "142", "bibliographic_titles": [{"bibliographic_title": "社会科学論集"}, {"bibliographic_title": "SHAKAIKAGAKU-RONSHU (The Social Science Review)", "bibliographic_titleLang": "en"}]}]}, "item_120_date_31": {"attribute_name": "作成日", "attribute_value_mlt": [{"subitem_date_issued_datetime": "2014-08-19", "subitem_date_issued_type": "Created"}]}, "item_120_description_19": {"attribute_name": "概要", "attribute_value_mlt": [{"subitem_description": "Japanese big pharmaceutical companies have performed M\u0026A in order to increase revenue and profit since 2000. However, their profitability was in decline between 2006 and 2012.\nThis paper focuses on value-added productivity and examines the factors leading to the decline of profitability in these companies. As a basis for labor productivity measures, value added per employee is used to measure the effectiveness of an organization. With respect to this measure, it is not clear why value-added productivity was in decline in these companies between 2006 and 2012.\nTherefore, the author proposes value added by personnel expenses as a measure of value-added productivity, which is composed as two factors: capital intensity of labor × capital productivity.\nOn the other hand, capital productivity = sales to operating assets × value added to sales. The findings are as follows: M\u0026A increased capital intensity of labor through the growth of intangible assets (e. g. goodwill). Therefore, M\u0026A negatively impacted value-added productivity.\nIn this situation, Astellas Pharmaceutical and Eisai Pharmaceutical are trying to improve capital productivity through reconstruction of R\u0026D organization with respect to increasing sales to operating assets and value added to sales.", "subitem_description_type": "Other"}]}, "item_120_description_20": {"attribute_name": "目次", "attribute_value_mlt": [{"subitem_description": "1.本研究の課題と方法\n2.労働生産性指標の検討\n3.付加価値生産性の理論と測定\n4.医薬品企業における付加価値生産性の分析\n5.結論", "subitem_description_type": "Other"}]}, "item_120_description_29": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"subitem_description": "text", "subitem_description_type": "Other"}]}, "item_120_description_30": {"attribute_name": "フォーマット", "attribute_value_mlt": [{"subitem_description": "application/pdf", "subitem_description_type": "Other"}]}, "item_120_identifier_registration": {"attribute_name": "ID登録", "attribute_value_mlt": [{"subitem_identifier_reg_text": "10.24561/00017017", "subitem_identifier_reg_type": "JaLC"}]}, "item_120_publisher_11": {"attribute_name": "出版者名", "attribute_value_mlt": [{"subitem_publisher": "埼玉大学経済学会"}]}, "item_120_publisher_12": {"attribute_name": "出版者名(別言語)", "attribute_value_mlt": [{"subitem_publisher": "The Economics Society of Saitama University"}]}, "item_120_relation_7": {"attribute_name": "著者 外部リンク", "attribute_value_mlt": [{"subitem_relation_name": [{"subitem_relation_name_text": "http://s-read.saitama-u.ac.jp/researchers/pages/researcher/dfPmFSBx"}], "subitem_relation_type_id": {"subitem_relation_type_id_text": "http://s-read.saitama-u.ac.jp/researchers/pages/researcher/dfPmFSBx", "subitem_relation_type_select": "URI"}}]}, "item_120_source_id_14": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "05597056", "subitem_source_identifier_type": "ISSN"}]}, "item_120_text_27": {"attribute_name": "版", "attribute_value_mlt": [{"subitem_text_value": "[出版社版]"}]}, "item_120_text_3": {"attribute_name": "著者 ローマ字", "attribute_value_mlt": [{"subitem_text_value": "KANEKO, Shigeru"}]}, "item_120_text_32": {"attribute_name": "アイテムID", "attribute_value_mlt": [{"subitem_text_value": "KY-AN00109186-142-13"}]}, "item_120_text_35": {"attribute_name": "公開日(XooNIps)", "attribute_value_mlt": [{"subitem_text_value": "Aug 20, 2014 13:57:39"}]}, "item_120_text_37": {"attribute_name": "最終更新日(XooNIps)", "attribute_value_mlt": [{"subitem_text_value": "Aug 21, 2014 16:13:34"}]}, "item_120_text_38": {"attribute_name": "公開日(XooNIps)", "attribute_value_mlt": [{"subitem_text_value": "Aug 20, 2014 13:57:39"}]}, "item_120_text_39": {"attribute_name": "更新履歴(XooNIps)", "attribute_value_mlt": [{"subitem_text_value": "Aug 21, 2014 抄録 を変更"}, {"subitem_text_value": "Aug 20, 2014 フリーキーワード, インデックス, 抄録, 目次, 著者, キーワード を変更"}]}, "item_120_text_4": {"attribute_name": "著者 所属", "attribute_value_mlt": [{"subitem_text_value": "埼玉大学経済学部教授"}]}, "item_120_text_40": {"attribute_name": "登録者(XooNIps)", "attribute_value_mlt": [{"subitem_text_value": "sucra_jim4"}]}, "item_120_text_41": {"attribute_name": "閲覧数(XooNIps)", "attribute_value_mlt": [{"subitem_text_value": "628"}]}, "item_120_text_42": {"attribute_name": "ダウンロード数(XooNIps)", "attribute_value_mlt": [{"subitem_text_value": "1011"}]}, "item_120_text_43": {"attribute_name": "XooNIps_インデックス", "attribute_value_mlt": [{"subitem_text_value": "sucra_jim4/埼玉大学/2014|Public/埼玉大学/経済学部|Public/ジャンル別/研究紀要/埼玉大学/社会科学論集|Public/主題別/社会科学/経営学/経営学"}]}, "item_120_text_44": {"attribute_name": "XooNIps_ITEM_KEY", "attribute_value_mlt": [{"subitem_text_value": "30894"}]}, "item_120_text_9": {"attribute_name": "年月次", "attribute_value_mlt": [{"subitem_text_value": "2014-6"}]}, "item_120_version_type_28": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "金子, 秀"}, {"creatorName": "カネコ, シゲル", "creatorNameLang": "ja-Kana"}], "nameIdentifiers": [{"nameIdentifier": "27704", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "dfPmFSBx", "nameIdentifierScheme": "研究者総覧", "nameIdentifierURI": "http://s-read.saitama-u.ac.jp/researchers/pages/researcher/dfPmFSBx"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2018-01-24"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "KY-AN00109186-142-13.pdf", "filesize": [{"value": "627.0 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 627000.0, "url": {"label": "KY-AN00109186-142-13.pdf", "url": "https://sucra.repo.nii.ac.jp/record/17023/files/KY-AN00109186-142-13.pdf"}, "version_id": "a19cd0a1-c9c2-4408-9aa7-ab36f78398c0"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "M\u0026A", "subitem_subject_scheme": "Other"}, {"subitem_subject": "value added productivity", "subitem_subject_scheme": "Other"}, {"subitem_subject": "goodwill", "subitem_subject_scheme": "Other"}, {"subitem_subject": "capital productivity", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "付加価値生産性の研究 : 医薬品企業の事例《研究ノート》", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "付加価値生産性の研究 : 医薬品企業の事例《研究ノート》"}]}, "item_type_id": "120", "owner": "3", "path": ["396"], "permalink_uri": "https://doi.org/10.24561/00017017", "pubdate": {"attribute_name": "公開日", "attribute_value": "2014-08-20"}, "publish_date": "2014-08-20", "publish_status": "0", "recid": "17023", "relation": {}, "relation_version_is_last": true, "title": ["付加価値生産性の研究 : 医薬品企業の事例《研究ノート》"], "weko_shared_id": -1}
付加価値生産性の研究 : 医薬品企業の事例《研究ノート》
https://doi.org/10.24561/00017017
https://doi.org/10.24561/0001701733e2d9bb-b00a-45c5-8f52-ccde6f39c5df
名前 / ファイル | ライセンス | アクション |
---|---|---|
KY-AN00109186-142-13.pdf (627.0 kB)
|
|
Item type | 紀要論文 / Departmental Bulletin Paper(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2014-08-20 | |||||
タイトル | ||||||
タイトル | 付加価値生産性の研究 : 医薬品企業の事例《研究ノート》 | |||||
言語 | ||||||
言語 | jpn | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | M&A | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | value added productivity | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | goodwill | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | capital productivity | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | departmental bulletin paper | |||||
ID登録 | ||||||
ID登録 | 10.24561/00017017 | |||||
ID登録タイプ | JaLC | |||||
タイトル(別言語) | ||||||
その他のタイトル | Value-Added Productivity in Big Japanese Pharmaceutical Companies | |||||
著者 |
金子, 秀
× 金子, 秀 |
|||||
著者 ローマ字 | ||||||
KANEKO, Shigeru | ||||||
著者 所属 | ||||||
埼玉大学経済学部教授 | ||||||
書誌情報 |
社会科学論集 en : SHAKAIKAGAKU-RONSHU (The Social Science Review) 巻 142, p. 179-209, 発行日 2014 |
|||||
年月次 | ||||||
2014-6 | ||||||
出版者名 | ||||||
出版者 | 埼玉大学経済学会 | |||||
出版者名(別言語) | ||||||
出版者 | The Economics Society of Saitama University | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 05597056 | |||||
概要 | ||||||
内容記述タイプ | Other | |||||
内容記述 | Japanese big pharmaceutical companies have performed M&A in order to increase revenue and profit since 2000. However, their profitability was in decline between 2006 and 2012. This paper focuses on value-added productivity and examines the factors leading to the decline of profitability in these companies. As a basis for labor productivity measures, value added per employee is used to measure the effectiveness of an organization. With respect to this measure, it is not clear why value-added productivity was in decline in these companies between 2006 and 2012. Therefore, the author proposes value added by personnel expenses as a measure of value-added productivity, which is composed as two factors: capital intensity of labor × capital productivity. On the other hand, capital productivity = sales to operating assets × value added to sales. The findings are as follows: M&A increased capital intensity of labor through the growth of intangible assets (e. g. goodwill). Therefore, M&A negatively impacted value-added productivity. In this situation, Astellas Pharmaceutical and Eisai Pharmaceutical are trying to improve capital productivity through reconstruction of R&D organization with respect to increasing sales to operating assets and value added to sales. |
|||||
目次 | ||||||
内容記述タイプ | Other | |||||
内容記述 | 1.本研究の課題と方法 2.労働生産性指標の検討 3.付加価値生産性の理論と測定 4.医薬品企業における付加価値生産性の分析 5.結論 |
|||||
版 | ||||||
[出版社版] | ||||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
資源タイプ | ||||||
内容記述タイプ | Other | |||||
内容記述 | text | |||||
フォーマット | ||||||
内容記述タイプ | Other | |||||
内容記述 | application/pdf | |||||
作成日 | ||||||
日付 | 2014-08-19 | |||||
日付タイプ | Created | |||||
アイテムID | ||||||
KY-AN00109186-142-13 |